TeselaGen Biotechnology Inc. has announced the launch of its Starter Edition, a version of the AI-enabled Operating System for Biotechnology R&D and manufacturing, that supports early-stage biotech companies that are ready to scale.
TeselaGen Launches Starter Edition for Early-Stage Biotechs
TeselaGen’s software has always made the process of developing biological R&D easier for established, multinational companies. However, the company has taken a step forward in supporting early-stage biotechs, by launching TeselaGen’s Starter Edition. This version provides innovative, cost-effective, and user-friendly technology to streamline laboratory processes, aiding in the scaling of research, and developing bio-based medicines with a shorter go-to-market timeline.
Ourobio Testimonials: Improved R&D Processes with Starter Edition
Ourobio, one of the early adopters of TeselaGen’s Starter Edition, expressed the benefits of using the software for their DNA assembly design process. The software allowed them to save countless hours, reduce costs, and streamline laboratory procedures to produce high-throughput DNA library construction. Alec Brewer, CEO of Ourobio, commended TeselaGen’s customer support and intuitive interface, stating that the Starter Edition provides accessible and incredible functionality at a reasonable price.
How TeselaGen’s Starter Edition Enables Rapid Biotech Prototyping
Startups, such as Ourobio, will benefit from TeselaGen’s focused tools designed to streamline processes and build an artificial intelligence-powered enterprise platform. With its automated DNA assembly design, built-in inventory checking capabilities, and centralized data storage, biotech startups can efficiently complete the research and development process, prototype new ideas rapidly, and access comprehensive records of past research. TeselaGen’s scalable Starter Edition will nurture startups in making an impact in the biotech industry.
In conclusion, TeselaGen’s Starter Edition is a game-changer for biotech startups who want to shorten their go-to-market timeline while accelerating scalability. Startups can focus on what they do best, while TeselaGen enhances biological R&D processes, from concept to completion.
